Literature DB >> 11984446

Microflora changes with the use of a vaginal microbicide.

Jennifer G Clarke1, Jeffrey F Peipert, Sharon L Hillier, Walter Heber, Lori Boardman, Thomas R Moench, Kenneth Mayer.   

Abstract

BACKGROUND: The rate of HIV transmission is increasing more in women than in any other group. There is an urgent need for the development of microbicides with activity against this virus that women can use during intercourse. These products must be convenient, effective, and safe, and ideally they will cause minimal disruption in the normal vaginal ecosystem. GOAL: The objective of this study was to evaluate changes in vaginal microflora, specifically Lactobacillus species, with the use of BufferGel. STUDY
DESIGN: A prospective cohort study was performed to evaluate the change in vaginal flora before and after BufferGel use. BufferGel was applied vaginally once or twice daily for 14 days by low-risk abstinent and monogamous women.
RESULTS: There was no change in frequency of Lactobacillus species after BufferGel use. However, there was a decrease in H2O2-producing lactobacilli (from 4.9 x 107 to 1.1 x 107 cfu; P = 0.001). The proportion of facultative gram-negative rods present increased from 27% to 65% after BufferGel use, whereas obligately anaerobic microbes decreased from 62% to 38%.
CONCLUSION: Use of BufferGel once or twice daily for 14 days resulted in no clinically significant change in Lactobacillus colonization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11984446     DOI: 10.1097/00007435-200205000-00007

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  8 in total

Review 1.  Vaginal drug delivery systems for HIV prevention.

Authors:  Lisa Cencia Rohan; Alexandra B Sassi
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

2.  Inactivation of human immunodeficiency virus type 1 by porphyrins.

Authors:  Andrei N Vzorov; Dabney W Dixon; Jenna S Trommel; Luigi G Marzilli; Richard W Compans
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

3.  Safe and sustained vaginal delivery of pyrimidinedione HIV-1 inhibitors from polyurethane intravaginal rings.

Authors:  Todd J Johnson; Priya Srinivasan; Theodore H Albright; Karen Watson-Buckheit; Lorna Rabe; Amy Martin; Chou-Pong Pau; R Michael Hendry; Ron Otten; Janet McNicholl; Robert Buckheit; James Smith; Patrick F Kiser
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

4.  Soluble Immune Mediators and Vaginal Bacteria Impact Innate Genital Mucosal Antimicrobial Activity in Young Women.

Authors:  Rebecca Pellett Madan; Charlene S Dezzutti; Lorna Rabe; Sharon L Hillier; Jeanne Marrazzo; Ian McGowan; Barbra A Richardson; Betsy C Herold
Journal:  Am J Reprod Immunol       Date:  2015-06-26       Impact factor: 3.886

5.  Impact of Dapivirine and Placebo Vaginal Rings on the Microbiota of Adolescent, Lactating, and Postmenopausal Females.

Authors:  Michele N Austin; Leslie A Meyn; Hilary A Avolia; Melinda A Petrina; Lisa A Cosentino; Calins Alphonse; Beatrice A Chen; Katherine Bunge; Lisa Noguchi; Richard Beigi; Kathleen Squires; Sharon L Hillier
Journal:  J Infect Dis       Date:  2022-06-15       Impact factor: 7.759

6.  First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacy.

Authors:  Peter A Anton; Terry Saunders; Julie Elliott; Elena Khanukhova; Robert Dennis; Amy Adler; Galen Cortina; Karen Tanner; John Boscardin; William G Cumberland; Ying Zhou; Ana Ventuneac; Alex Carballo-Diéguez; Lorna Rabe; Timothy McCormick; Henry Gabelnick; Christine Mauck; Ian McGowan
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

7.  Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.

Authors:  Inês Bártolo; Ana Rita Diniz; Pedro Borrego; João Pedro Ferreira; Maria Rosário Bronze; Helena Barroso; Rui Pinto; Carlos Cardoso; João F Pinto; Rafael Ceña Diaz; Pilar Garcia Broncano; Maria Angel Muñoz-Fernández; Nuno Taveira
Journal:  PLoS One       Date:  2018-04-18       Impact factor: 3.240

8.  Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides.

Authors:  A Robert Neurath; Nathan Strick; Yun-Yao Li
Journal:  BMC Infect Dis       Date:  2002-11-21       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.